A5068554668- COVID-19 and healthcare impacts
- Cardiac, Anesthesia and Surgical Outcomes
- Prostate Cancer Treatment and Research
- Trauma and Emergency Care Studies
- Radiopharmaceutical Chemistry and Applications
- Prostate Cancer Diagnosis and Treatment
- Advances in Oncology and Radiotherapy
- Health Systems, Economic Evaluations, Quality of Life
- Peptidase Inhibition and Analysis
- Healthcare cost, quality, practices
- Surgical site infection prevention
- Respiratory Support and Mechanisms
- COVID-19 Clinical Research Studies
- Global Cancer Incidence and Screening
- Pancreatitis Pathology and Treatment
- Patient-Provider Communication in Healthcare
- Dermatological and COVID-19 studies
- Ultrasound in Clinical Applications
- Diagnosis and Treatment of Venous Diseases
- Radiation Dose and Imaging
- Palliative Care and End-of-Life Issues
- Venous Thromboembolism Diagnosis and Management
Weill Cornell Medicine
2021-2023
Cornell University
2021-2023
University of Birmingham
2020-2021
NIHR Birmingham Biomedical Research Centre
2021
Yorkshire Cancer Research
2021
Urology Foundation
2021
Association for Cancer Surgery
2021
Merck (Germany)
2020
Stryker (United Kingdom)
2020
Pfizer (United Kingdom)
2020
The primary objective was to compare the overall diagnostic performance, presented as detection rate of 68Ga-PSMA-HBED-CC positron emission tomography/magnetic resonance imaging (PSMA PET/MRI) versus conventional, multiparametric MRI (mpMRI) in a population patients with biochemically recurrent prostate cancer. In conjunction this analysis, secondary objectives included evaluation stratified by PSA levels and treatment modality.A total 165 PSMA PET were performed from April 2018 May 2021,...
Prostate cancer (PC) staging with conventional imaging often includes multiparametric magnetic resonance (MR) of the prostate, computed tomography (CT) chest, abdomen, and pelvis, whole-body bone scintigraphy. The recent development highly sensitive specific prostate membrane antigen (PSMA) positron emission (PET) has suggested that prior techniques may be insufficiently or specific, particularly when evaluating small pathologic lesions. As PSMA PET/CT is considered to superior for multiple...
The clinical utility of gallium 68 (